Meeting of the Advisory Committee on Heritable Disorders in Newborns and Children

Cited as:85 FR 41242
Court:Health Resources And Services Administration
Publication Date:09 Jul 2020
Record Number:2020-14813
Federal Register, Volume 85 Issue 132 (Thursday, July 9, 2020)
[Federal Register Volume 85, Number 132 (Thursday, July 9, 2020)]
                [Notices]
                [Page 41242]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2020-14813]
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                Health Resources and Services Administration
                Meeting of the Advisory Committee on Heritable Disorders in
                Newborns and Children
                AGENCY: Health Resources and Services Administration (HRSA), Department
                of Health and Human Services (HHS).
                ACTION: Notice.
                -----------------------------------------------------------------------
                SUMMARY: In accordance with the Federal Advisory Committee Act, section
                1111(g) of the Public Health Service Act, this notice announces that
                the Advisory Committee on Heritable Disorders in Newborns and Children
                (ACHDNC or Committee) has scheduled a public meeting. Information about
                the ACHDNC and the agenda for this meeting can be found on the ACHDNC
                website at https://www.hrsa.gov/advisory-committees/heritable-disorders/index.html.
                DATES: Thursday, August 6, 2020, from 10:00 a.m. to 3:00 p.m. Eastern
                Time (ET) and Friday, August 7, 2020, from 10:00 a.m. to 3:00 p.m. ET.
                ADDRESSES: This meeting will be held via webinar. While this meeting is
                open to the public, advance registration is required. Please visit the
                ACHDNC website for information on registration: https://www.hrsa.gov/advisory-committees/heritable-disorders/index.html. The deadline for
                online registration is 12:00 p.m. ET on August 6, 2020. Instructions on
                how to access the meeting via webcast will be provided upon
                registration.
                FOR FURTHER INFORMATION CONTACT: Alaina Harris, Maternal and Child
                Health Bureau, HRSA, 5600 Fishers Lane, Room 18W66, Rockville, Maryland
                20857; 301-443-0721; or [email protected].
                SUPPLEMENTARY INFORMATION: ACHDNC provides advice and recommendations
                to the Secretary of HHS (Secretary) on the development of newborn
                screening activities, technologies, policies, guidelines, and programs
                for effectively reducing morbidity and mortality in newborns and
                children having, or at risk for, heritable disorders. ACHDNC's
                recommendations regarding inclusion of additional conditions for
                screening, following adoption by the Secretary, are evidence-informed
                preventive health services provided for in the comprehensive guidelines
                supported by HRSA through the Recommended Uniform Screening Panel
                (RUSP) pursuant to section 2713 of the Public Health Service Act (42
                U.S.C. 300gg-13). Under this provision, non-grandfathered group health
                plans and health insurance issuers offering group or individual health
                insurance are required to provide insurance coverage without cost-
                sharing (a co-payment, co-insurance, or deductible) for preventive
                services for plan years (i.e., policy years) beginning on or after the
                date that is one year from the Secretary's adoption of the condition
                for screening.
                 During the August 6-7, 2020, meeting, ACHDNC will hear from experts
                in the fields of public health, medicine, heritable disorders, rare
                disorders, and newborn screening. Agenda items will include updates on
                the Committee's evidence review process. There will be no Committee
                votes on recommending new conditions for the RUSP. Agenda items are
                subject to changes as priorities dictate. Refer to the ACHDNC website
                for any updated information concerning the meeting. Information about
                the ACHDNC, a roster of members, as well as past meeting summaries, are
                also available on the ACHDNC website.
                 Members of the public will have the opportunity to provide
                comments. Public participants may submit written statements in advance
                of the scheduled meeting. Oral comments will be honored in the order
                they are requested and may be limited as time allows. Requests to
                provide a written statement or make oral comments to the ACHDNC must be
                submitted via the registration website by Monday, August 3, 2020, by
                12:00 p.m. ET.
                 Individuals who need special assistance or another reasonable
                accommodation should notify Alaina Harris at the address and phone
                number listed above at least 10 business days prior to the meeting.
                Maria G. Button,
                Director, Executive Secretariat.
                [FR Doc. 2020-14813 Filed 7-8-20; 8:45 am]
                BILLING CODE 4165-15-P